[Efficacy of duspatalin in the treatment and prophylaxis of postcholecystectomic syndrome].
Lipnitskiĭ
E M
EM
Isakova
O V
OV
Dzhadzhanidze
A D
AD
Ardatskaia
M D
MD
D000328:Adult; D000368:Aged; D001421:Bacteria, Anaerobic / Q000254:growth & development; D001647:Bile Acids and Salts / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D005232:Fatty Acids, Volatile / Q000032:analysis; D005243:Feces / Q000737:chemistry; D005260:Female; D006801:Humans; D007422:Intestines / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D010627:Phenethylamines / Q000008:administration & dosage / Q000627:therapeutic use*; D017562:Postcholecystectomy Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D011788:Quality of Life
D001647:Bile Acids and Salts; D015415:Biomarkers; D005232:Fatty Acids, Volatile; D010276:Parasympatholytics; D010627:Phenethylamines; C005096:mebeverine